14 results
DEFM14A
LABP
Landos Biopharma Inc
25 Apr 24
Proxy related to merger
5:07pm
and other applicable policies and procedures; (ii) training on the code
A-19
of conduct, policies and procedures for all employees; (iii) an auditing
PREM14A
LABP
Landos Biopharma Inc
15 Apr 24
Preliminary proxy related to merger
5:18pm
of the following elements: (i) a code of conduct and other applicable policies and procedures; (ii) training on the code
A-19
of conduct, policies
DEFA14A
LABP
Landos Biopharma Inc
25 Mar 24
Additional proxy soliciting materials
9:19am
of conduct and other applicable policies and procedures; (ii) training on the code of conduct, policies and procedures for all employees; (iii
8-K
EX-2.1
LABP
Landos Biopharma Inc
25 Mar 24
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
8:54am
policies and procedures; (ii) training on the code of conduct, policies and procedures for all employees; (iii) an auditing and monitoring function; (iv
10-K
m3h1ou2
31 Mar 21
Annual report
5:03pm
424B4
2zk077 sr4
4 Feb 21
Prospectus supplement with pricing info
5:02pm
S-1/A
m4sarhqs7hsprr zs4
28 Jan 21
IPO registration (amended)
9:12am
S-1
we07 uqbvevg
13 Jan 21
IPO registration
5:07pm
DRS/A
759qwt 10ccux277o3
1 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
kpoflvlzmgh6nix w60
1 Sep 20
Draft registration statement (amended)
12:00am
DRS
sfblsq63 36w0
24 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next